Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.39 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 4/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | NQO2 | P16083 | 1/20 | 0.36 |
| ▸ | HEXA | P06865 | 1/20 | 0.35 |
| ▸ | HEXB | P07686 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15112345 | 0.83 | CNR2 (0.56) | CNR2 | |
| SCHEMBL18247631 | 0.81 | CYP19A1 (0.43) | CNR2HTR2CUSP2MAPK1FABP4 | |
| SCHEMBL23927911 | 0.81 | HTR2C (0.54) | HTR2CHTR6HEXAHEXBHTR2A | |
| SCHEMBL5334673 | 0.81 | CNR2 (0.43) | CNR2USP2MAPK1 | |
| SCHEMBL8123525 | 0.80 | CNR2 (0.37) | CNR2HTR2CUSP2MAPK1FABP4 | |
| SCHEMBL7997702 | 0.78 | HTR2C (0.61) | HTR2CHTR2A | |
| SCHEMBL28375979 | 0.76 | KCNA3 (0.53) | KDM4E | |
| SCHEMBL1092786 | 0.75 | CDK4 (0.45) | CNR2HTR2CMAPK1FABP4MCHR1 | |
| SCHEMBL26660651 | 0.75 | GRM2 (0.45) | CNR2 | |
| SCHEMBL6919488 | 0.75 | ALDH1A1 (0.41) | USP2MAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0749313-A4 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | LILLY CO ELI (US) | 2001-10-24 | — | — | EP | disclosed |
| US-5736544-A | ADMINISTERING TO TREAT MIGRAINE HEADACHES IN MAMMALS | ELI LILLY AND COMPANY (US) | 1998-04-07 | — | — | US | disclosed |
| US-5705519-A | ADMINISTERING A SUBSTITUTED INDOLE TO A MAMMAL | ELI LILLY AND COMPANY (US) | 1998-01-06 | — | — | US | disclosed |
| US-5688807-A | ANTIDEPRESSANTS, ANXIETY, UROGENITAL DISORDERS, HYPOTENSIVES, CARDIOVASCULAR DISORDERS | ELI LILLY AND COMPANY (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0751770-A4 | 8-SUBSTITUTED TETRAHYDRO-BETA-CARBOLINES | LILLY CO ELI (US) | 1997-06-11 | — | — | EP | disclosed |
| US-5631265-A | CHEMICAL INTERMEDIATES WITH CENTRAL NERVOUS SYSTEM ACTIVITY | ELI LILLY AND COMPANY (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0751770-A1 | 8-SUBSTITUTED TETRAHYDRO-BETA-CARBOLINES | ELI LILLY AND COMPANY (US) | 1997-01-08 | — | — | EP | disclosed |
| EP-0749313-A1 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| WO-1995024200-A1 | METHOD FOR TREATING 5HT2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |
| WO-1995024191-A1 | 8-SUBSTITUTED TETRAHYDRO-BETA-CARBOLINES | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |